How can I differentiate between patients who require bronchoscopy and those who can be managed with non-invasive investigations?

To differentiate between patients who require bronchoscopy and those who can be managed with non-invasive investigations, consider the following approach:

• Initial assessment should include history, symptoms, and signs suggestive of respiratory disease, supported by spirometry and chest radiograph to exclude other pathologies.
• Non-invasive investigations such as sputum culture, CT thorax, ECG, serum natriuretic peptides, echocardiogram, and transfer factor for carbon monoxide (TLCO) are appropriate for most patients to identify infections, cardiac status, or alternative lung diagnoses.
• Bronchoscopy is generally reserved for cases where non-invasive tests are inconclusive or when there is suspicion of alternative diagnoses that require direct airway visualization or sampling, such as unexplained haemoptysis, suspected malignancy, or persistent lung infiltrates not explained by imaging.
• Patients with symptoms like haemoptysis, chest pain, or abnormal imaging findings that cannot be clarified by CT or sputum analysis should be considered for bronchoscopy.
• In stable COPD patients without atypical features or suspicious imaging, management with non-invasive investigations and monitoring is appropriate.

This approach ensures bronchoscopy is used selectively for diagnostic clarification when non-invasive methods are insufficient, aligning with NICE recommendations on COPD and respiratory disease management.

References: ¹